Sonoma Pharma Announces U.S. Commercialization Of Loyon For Relief Of Scaling, Burning And Itching Associated With Various Dermatoses Including Seborrhea And Seborrheic Dermatitis Post author:Sam Post published:October 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Zafgen Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) October 12, 2017 Longtime CEO at Bay Area's OncoMed Steps Down January 4, 2018 How Boston Scientific Is Getting Drug-Eluting Stents And Balloons Into Legs April 13, 2017